Peripheral artery disease trials in Germany

In Germany 16 Also abroad 233

11 of 16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A contrast medium sparing strategy using automated Carbon Dioxide Injection during PERIpheral vascular interventions for PREVENTion of Major Adverse Kidney Events (MAKE): the PeriPREVENT randomized controlled trial
Where
Alsfeld, Bad Krozingen, Berlin, Bonn, Chemnitz, Coburg, Flensburg, Frankfurt Am Main, Hamburg, Leipzig, Munich, Weinheim
Age
18 years and over
People
1,960 worldwide
Run by
Universitaet Leipzig
See details and how to join2024-512876-37-00
Phase 3Not yet taking people in Germany
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
Where
Bad Friedrichshall, Bad Krozingen, Bremen, Dresden, Hamburg, Immenstadt I. Allgäu, Karlsruhe, Muenster, Munich
Age
18 years and over
People
7,050 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT07318610 · EU 2025-522954-37-00
Phase 3Taking people
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Where
Essen, Hamburg
Age
18 years and over
People
6,150 worldwide
Run by
Population Health Research Institute
See details and how to joinNCT04774159 · EU 2024-512091-35-01
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Berlin, Hessen, Kaiserslautern, Kiel, Leipzig, Mainz, Villingen-Schwenningen
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
Phase 1/2Taking people
Effect of TRI-001 in patients with chronic limb threatening ischemia
Where
Dresden, Duesseldorf, Hamburg, Heidelberg, Leipzig, Muenster
Age
18 years and over
People
52
Run by
Ferring Ventures GmbH
See details and how to join2024-517765-16-00
Phase 4Taking people
Early TRIPLE versus dual LIPID lowering treatment in peOple with atherosclerotic cardiovascular disease and hypercholesterolemia Undergoing elecTive revascularisation
Where
Dresden, Mainz, Regensburg
Age
18 years and over
People
160 worldwide
Run by
Medical University Of Graz
See details and how to join2026-525917-29-00
No phaseTaking people
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
Where
Bad Krozingen, Münster, Regensburg, Stuttgart
Age
18 years and over
People
244 worldwide
Run by
W.L.Gore & Associates
See details and how to joinNCT05811364
No phaseTaking people
Comparison of a Lithotripsy vs Standard Preparation Followed by Stenting With Supera Stent in Femoropopliteal Lesions
Where
Leipzig
Age
18 years and over
People
120
Run by
University of Leipzig
See details and how to joinNCT06112171
No phaseTaking people
SELUTION4BTK Trial
Where
Arnsberg, Bad Krozingen, Buchholz, Coburg, Essen, Tübingen
Age
18 years and over
People
376 worldwide
Run by
M.A. Med Alliance S.A.
See details and how to joinNCT05055297
No phaseTaking people
Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)
Where
Düsseldorf
Age
18 years and over
People
200
Run by
Heinrich-Heine University, Duesseldorf
See details and how to joinNCT06124586
No phaseTaking people
Distrupt Stiffness Trial
Where
Essen
Age
18 years to 85 years
People
40
Run by
University Hospital, Essen
See details and how to joinNCT07130526